Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 133 B, Issue 1, 2005, Pages 57-63

  Smith, Karen Müller ^a   Bauer, Lorri ^b   Fischer, Mariellen ^b   Barkley, Russell ^c   Navia, Bradford A ^a,d,e  

^a TUFTS UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Research Laboratories in Psychiatry   (United States)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Dopamine; NR4A2; Nurr1

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1;

3' UNTRANSLATED REGION; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CELL LINE; CHILD; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; FAMILY STUDY; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; SIBLING; SINGLE STRAND CONFORMATION POLYMORPHISM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASE SEQUENCE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENOTYPE; HAPLOTYPES; HELA CELLS; HUMANS; LINKAGE DISEQUILIBRIUM; LUCIFERASES; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 12944286495     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30127     Document Type: Article

References (44)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th edn. Washington D.C.
2. Applegate B, Lahey BB, Hart EL, Waldman I, Biederman J, Hynd GW, Barkley RA, Ollendick T, Frick PJ, Greenhill L, et al. 1997. Validity of the age of onset criterion for ADHD: A report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry, 36:1211-1221.
3. Bakker SC, van de Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ, van't Slot R, Minderaa RB, Gunning WB, Pearson PL, Sinke RJ. 2003. A whole-genome scan in 164 Dutch sib pairs with Attention Deficit Hyperactivity Disorder: Suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 72:1251-1260.
4. Barkley RA. 1997. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121:65-94.
5. Barkley RA, Biederman J. 1997. Towards a broader definition of the age of onset criterion for attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:1204-1210.
6. Barkley RA, Fischer M, Edelbrock CS, Smallish L. 1990. The adolescent outcome of hyperactive children diagnosed by research criteria, I: An 8 year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-557.
7. Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jonsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlamnn T, Anvret M, Olson L. 2000. NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet 96(6):808-813.
8. Castellanos FX. 1997. Toward a pathophisiology of attention deficit/hyperactivity disorder. Clin Pediatr 36(7):381-393.
9. Castillo S, Baffi J, Palkovits M, Goldstein DS, Kopin IJ, Witta J, Magnuson MA, Nikodem VM. 1998. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci 11:36-46.
10. Cazorla P, Smidt M, O'Malley K, Burbach J. 2000. A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter. J Neurochem 74:1829-1837.
11. Clayton D. 1999. A generalization of the transmission disequilibrium test for uncertain haplotype transmission. Am J Hum Gent 65:1170-1177.
12. Clayton D, Jones HB. 1999. Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Gent 65:1161-1169.
13. Chen Y-H, Tsai M-T, Shaw C-K, Chen C-H. 2001. Mutational analysis of the human NR4A2 gene for midbrain dopaminergic neurogenesis in schizophrenic patients. Am J Med Genet (Neuropsychiatric Genetics) 105:753-757.
14. Edelbrock C, Costello AJ. 1998. Convergence between statistically derived behavior problem syndromes and child psychiatric diagnoses. J Abnorm Child Psychol 16:219-231.
15. Eells JB, Rives JE, Yeung SK, Nikodem VM, 2001. In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups. J Neurosci Res 64:322-330.
16. Faraone SV, Doyle AE, Mick E, Biederman J. 2001. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052-1057.
17. Hayashi K, Kukita Y, Inazuka M, Tahira T. 1998. Single-stranded conformation polymorphism analysis. Mutation detection a practical approach. In: Cotton RGH, Edkins E, Forrest S. editors. Oxford Press.
18. Ishiguro H, Okubo Y, Ohtsuki T, Yamakawa-Kobayashi K, Arinami T. 2002. Mutational analysis of the retinoid x receptor beta, nuclear-related receptor 1, and peroxisome proliferator-activated receptor in schizophrenia and alcohol dependence: Possible haplotype association of nuclear related receptor gene to alcohol dependence. Am J Med Genet 114:15-23.
19. Iwawaki T, Kohno K, Kobayashi K. 2000. Identification of a potential Nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells. Biochem Biophys Res Comm 274:590-595.
20. Kaufman A, Kaufman N. 1984. The Kaufman Brief Intelligence Teat. Circle Pines, MN: American Guidance Service.
21. Kandel ER, Schwartz ZJH, Jessell TM. 1991. Principles of neural science, 3rd edn. Appleton and Lange. Norwalk, Connecticut, USA.
22. Le W, Conneely O, Zou L, He Y, Saucedo-Cardenas O, Jankovic J, Mosier DR, Appel SH. 1999. Selective agenesis of mesencephalic dopaminergic neurons in Nurr-deficient mice. Exp Neurol 159:451-458.
23. Le W-D, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis D. 2003. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33:85-89.
24. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
25. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, Lee SY, Levy F, Kent L, et al. 2004. Joint analysis of the DRD5 marker concludes association with attention deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Gent 74:348-356.
26. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM. 2002. Dopamine system genes and attention deficit hyperactivity disorder: A meta-analysis. Psychiatr Genet 12(4):207-215.
27. Mercugliano M. 1995. Neurotransmitter alterations in attention deficit/hyperactivity disorder. Ment Retard Dev Disabil Res Rev 1:220-226.
28. Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C, Cantor RM, McCracken JT, McGough JJ, Nelson SF, et al. 2003. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: Suggestive linkage on 17p11. Am J Hum Genet 72:1268-1279.
29. Perrone-Capano C, Da Pozzo P, di Pozzo U. 2000. Epigenetic cues in midbrain dopaminergic neuron development. Neurosci Biobehav Rev 24:119-124.
30. Raymond M, Rousset F. 1995. GENEPOP (version 1.2): Population genetics software for exact tests and ecumenicism. J Heredity 86:248-249.
31. Sacchetti P, Brownschidle L, Granneman J, Bannon M. 1999. Characterization of the 5′ flanking region of the human dopamine transporter gene. Mol Brain Res 74:167-174.
32. Sacchetti P, Mitchell TR, Granneman J, Bannon M. 2001. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76:1565-1572.
33. Saucedo-Cardenas O, Quintana-Hau J, Le W-D, Smidt MP, Cox JJ, DeMayo F, Burbach PH, Conneely OM. 1998. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. PNAS 95:4013-4018.
34. Schimmel JJ, Crews L, Roffler-Tarlov S, Chikaraishi D. 1999. 4.5 kb of the rat tyrosine hydroxylase 5′ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors. Mol Brain Res 74:1-14.
35. Shelton T, Barkley R, Crosswait C, Moorehouse M, Fletcher K, Barret S, Jnenkins L, Metevia L, et al. 1998. Psychiatric and Psychological morbidity as a function of adaptive disability in preschool children with aggressive and hyperactive-impulsive-inattentive behavior. J Abnorm Child Psychol 26:475-494.
36. Smith KM, Daly MJ, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, Navia BA. 2003. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study. Am J Med Genet 119B(1):77-85.
37. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Gent 52(3):506-516.
38. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, Murias M, Moriarity J, Barr C, Smith M, Posner M. 2001. Dopamine genes and ADHD. Neurosci Biobehav Rev 24:21-25.
39. Tannock R. 1998. Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 39:65-100.
40. Thapar A, Holmes J, Poulton K, Harrington R. 1999. Genetic basis for attention deficit and hyperactivity. Br J Psychiatry 174:105-111.
41. Torii T, Kawari T, Nakamura S, Kawakami H. 1999. Organization of the human orphan nuclear receptor Nurr1 gene. Gene 230:225-232.
42. Wickelgren L. 1997. Getting the brain's attention. Science 278:35-37.
43. Xu P-Y, Liang R, Jankovic J, Hunter C, Zeng Y-X, Ashizawa T, Lai D, Le W-D. 2002. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology 58(6):881-884.
44. Zetterstrom R, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann KMS. 1997. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248-249.